Fig. 2.
Kaplan–Meier estimates of the progression-free survival of patients with PD-L1 expression (N=130, median PFS did not reach the study endpoint, P=0.018). PD-L1, programmed death ligand-1; PFS, progression-free survival.
Kaplan–Meier estimates of the progression-free survival of patients with PD-L1 expression (N=130, median PFS did not reach the study endpoint, P=0.018). PD-L1, programmed death ligand-1; PFS, progression-free survival.